Page 10 - Roche Diagnostics News Today

Roche Diagnostics and the Aga Khan University Hospital, Nairobi have signed a contract aimed at enhancing healthcare access in Kenya and East Africa by installing a fully automated diagnostics instrument at the Hospital.

INDIANAPOLIS – BioCrossroads today announced the agenda for its 2023 Life Sciences Summit, which will focus on Indiana’s leadership role in research and medical advances related to Alzheimer’s disease as well as in helping people who live with Alzheimer’s and caregivers manage the disease that a ...

A number of blood tests for Alzheimer's are being developed, and one is even now being sold to consumers, but none have been proven to be reliable, formally approved by regulators, or paid for by insurance companies.

Blood tests for Alzheimer's are needed to more widely diagnose the brain-wasting disease and understand its prevalence, but it will be another couple of years before they become an everyday tool, medical experts and company executives say. Blood testing is initially likely to be used to rule out Alzheimer's, with positive results signalling the need for more advanced diagnostics. Several...

This cluster randomized trial compares use of standard- vs small-volume blood collection tubes in decreasing rates of anemia and red blood cell transfusions amo

Blood tests for Alzheimer's are needed to more widely diagnose the brain-wasting disease and understand its prevalence, but it will be another couple of years before they become an everyday tool, medical experts and company executives say. Blood testing is initially likely to be used to rule out Alzheimer's, with positive results signaling the need for more advanced diagnostics. Several Alzheimer's blood tests are in the works – and one is already being sold to consumers ...

By Deena Beasley (Reuters) - Blood tests for Alzheimer's are needed to more widely diagnose the brain-wasting disease and understand its prevalence, b...

A number of blood tests for Alzheimer's are being developed, and one is even now being sold to consumers, but none have been proven to be reliable, formally approved by regulators, or paid for by insurance companies.

Old National Bank was named a 2023 Leading Disability Employer by the National Organization on Disability, a nonprofit that works to increase job opportunities for the 60% of working-age Americans

Were the GLP-1 receptor agonist drugs apparent benefits in STEP-HFpEF due solely to weight loss or additional mechanisms? The trial offers a clue, experts say.